74.29
0.21 (0.28%)
| Previous Close | 74.08 |
| Volume | 1,248,085 |
| Price / Earnings (Forward) | 13.91 |
| Price / Sales | 3.22 |
| Price / Book | 2.09 |
| 52 Weeks Range |
| Profit Margin | 7.39% |
| Operating Margin (TTM) | 16.43% |
| Diluted EPS (TTM) | 1.34 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Quarterly Earnings Growth (YOY) | 76.30% |
| Total Debt/Equity (MRQ) | 2.27% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 645.55 M |
| Levered Free Cash Flow (TTM) | 636.51 M |
| Return on Assets (TTM) | 5.84% |
| Return on Equity (TTM) | 4.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Globus Medical, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.45 |
|
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 100.63% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Burgundy Asset Management Ltd. | 30 Sep 2025 | 3,460,983 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| TOBIN JAMES R | - | 74.69 | -30,000 | -2,240,700 |
| Aggregate Net Quantity | -30,000 | |||
| Aggregate Net Value ($) | -2,240,700 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 74.69 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| TOBIN JAMES R | Director | 15 Sep 2026 | Sell (-) | 30,000 | 74.69 | 2,240,700 |
| TOBIN JAMES R | Director | 15 Sep 2026 | Option execute | 30,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |